Kallikrein 1 antibody (Internal Region)
Quick Overview for Kallikrein 1 antibody (Internal Region) (ABIN374847)
Target
See all Kallikrein 1 (KLK1) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Internal Region
-
Specificity
- This antibody reacts to KLK1.
-
Purification
- Affinity chromatography
-
Immunogen
- Peptide with sequence PNDECKKAHVQK, from the internal region of the protein sequence
-
-
-
-
Application Notes
-
Peptide ELISA: 1/2000. Western Blot: 1 - 3 μg/mL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 0,5 mg/mL
-
Buffer
- Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- Kallikrein 1 (KLK1)
-
Alternative Name
- KLK1 / Kallikrein-1
-
Background
- Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. Kallikrein 1 releases the vasoactive peptide, Lys-bradykinin, from low molecular weight kininogen. Low renal synthesis and urinary excretion of tissue kallikrein have been linked to hypertension in animals and humans and the kallikrein-kinin system may be involved in the development or progression of cardiovascular disease.Synonyms: EC 3.4.21.35, KLK-1, Kallikrein1, Kidney/pancreas/salivary gland kallikrein, Tissue kallikrein
-
Gene ID
- 3816
-
NCBI Accession
- NP_002248
-
UniProt
- P06870
-
Pathways
- Complement System
Target
-